Anti-inflammatory treatment using alpha melanocyte stimulating hormone (α-MSH) does not alter osteoblasts differentiation and fracture healing
Abstract Background Alpha-melanocyte-stimulating-hormone (α-MSH) has been identified as a new anti-inflammatory treatment compound in rheumatoid arthritis (RA) and other inflammatory diseases. However, its direct effect on bone cell differentiation or on bone regeneration, which is an inflammatory p...
Saved in:
Main Authors: | Johanna Graue, Melanie Timmen, Katharina Schmitz, Daniel Kronenberg, Markus Böhm, Kishor K. Sivaraj, M. Gabriele Bixel, Richard Stange |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-02-01
|
Series: | BMC Musculoskeletal Disorders |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12891-025-08374-9 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dual Role of α-MSH in Colitis Progression: Mediating Neutrophil Differentiation via Bone Marrow
by: Liao X, et al.
Published: (2025-02-01) -
Clinicopathological features of Lynch syndrome pedigrees with MSH2 c.351G>A gene variant
by: Shuai Zhang, et al.
Published: (2025-01-01) -
Il-6 and MSH3 in colorectal carcinoma: Expression, relationship, and prognostic significance in 171 colorectal carcinoma cases
by: Elif Kolay Bayram, et al.
Published: (2024-12-01) -
Balancing act: optimizing blue light for melanogenesis while minimizing cellular damage in primary human skin cells
by: Augustin C. Barolet, et al.
Published: (2025-01-01) -
DNA mismatch repair (MMR) genes expression in lung cancer and its correlation with different clinicopathologic parameters
by: Mayada Saad Farrag, et al.
Published: (2025-01-01)